help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-1072
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/3/1168    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burkhardt, M. S.
Right arrow Articles by Yeap, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burkhardt, M. S.
Right arrow Articles by Yeap, B. B.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*TESTOSTERONE
Related Collections
Right arrow Male Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 3 1168-1172
Copyright © 2006 by The Endocrine Society


BRIEF REPORT

Interaction between Testosterone and Apolipoprotein E {epsilon}4 Status on Cognition in Healthy Older Men

Melanie S. Burkhardt, Jonathan K. Foster, Roger M. Clarnette, S. A. Paul Chubb, David G. Bruce, Peter D. Drummond, Ralph N. Martins and Bu B. Yeap

School of Psychology (M.S.B., P.D.D.), Murdoch University, Murdoch, Western Australia 6150, Australia; Sir James McCusker Alzheimer’s Disease Research Unit (M.S.B., J.K.F., R.M.C., R.N.M.), School of Exercise, Biomedical, and Health Sciences, Edith Cowan University, and School of Psychiatry and Clinical Neurosciences, University of Western Australia, Hollywood Private Hospital, Nedlands 6009, Western Australia; Neurosciences Unit (J.K.F.), Health Department of Western Australia, East Perth Western Australia 6004, Australia; Departments of Geriatric Medicine (R.M.C., D.G.B.), Biochemistry (S.A.P.C.), and Endocrinology and Diabetes (B.B.Y.), Fremantle Hospital, Fremantle, Western Australia 6959, Australia; and School of Medicine and Pharmacology (R.M.C., D.G.B., B.B.Y.), University of Western Australia, Fremantle Hospital, Fremantle, Western Australia 6959, Australia

Address all correspondence and requests for reprints to: Professor Ralph N. Martins, Sir James McCusker Alzheimer’s Disease Research Unit, School of Exercise, Biomedical, and Health Sciences, Edith Cowan University, and School of Psychiatry and Clinical Neurosciences, University of Western Australia, c/o Hollywood Private Hospital, Nedlands, 6009 Western Australia, Australia. E-mail: r.martins{at}ecu.edu.au.

Context: Reduced testosterone levels have been implicated as a potential causative factor in cognitive decline with older age. Men who possess the apolipoprotein E (APOE) {epsilon}4 allele have an increased risk of developing Alzheimer’s disease; however, no studies have examined whether the influence of testosterone on cognition in healthy older men may be modulated by this genetic predisposition.

Objective: The objective of the study was to investigate the association between serum testosterone concentrations and cognitive performance in healthy older men, taking into account APOE {epsilon}4 status.

Design: This was a cross-sectional study conducted from 2003 to 2004.

Setting: The study population consisted of community-dwelling males residing in Perth, Western Australia.

Participants: Healthy men over 55 yr, free of cognitive impairment and dementia (n = 45), were included in the study.

Main Outcome Measures: Participants had fasting early morning blood samples for testosterone and SHBG and were assessed for mood as well as indices of general cognition, verbal and visual memory, executive functioning, working memory, and attention.

Results: There was a significant interaction between calculated free testosterone (FT) and APOE {epsilon}4 on general cognition (P = 0.01) and executive functioning, working memory, and attention (P < 0.01). Higher levels of FT were associated with better general cognition in non-{epsilon}4 carriers (P = 0.01). By contrast, in {epsilon}4 carriers higher FT levels were associated with lower scores on tests of executive functioning, working memory, and attention (P = 0.02). In men at increased risk for Alzheimer’s disease, higher testosterone levels were not associated with better cognitive function.

Conclusions: Cross-sectional and prospective studies of testosterone and cognition in older men should take into account APOE {epsilon}4 status.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society